Kao (4452) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Achieved strong profit recovery in 2024, surpassing targets due to structural reforms, higher value-added products, and improved brand loyalty, with operating income up 27.8% to JPY 146.6 billion and net sales up 6.3% to JPY 1.6284 trillion.
ROIC improved to 9.2% (from 4.1% in FY2023), with significant progress toward K27 targets and increased probability of achievement.
Optimization of cosmetics inventory in China was completed, with expected profit contribution in FY2025.
Entering a new stage in 2025, focusing on reformed earning power as a core engine for global growth, with the cosmetics business expected to contribute more.
The business environment remains uncertain due to global geopolitical risks, inflation, and economic slowdowns, particularly in China.
Financial highlights
Net sales rose 6.3% year-over-year to JPY 1.6284 trillion; excluding Forex, sales grew 3.3%.
Gross margin improved by 1.9 percentage points to 39.2%; operating margin at 9.0%.
Operating income increased by JPY 31.9 billion to JPY 146.6 billion; net income attributable to owners was JPY 107.8 billion, up 25.3% year-over-year; EPS rose 25.4% to JPY 231.94.
EBITDA surged to JPY 235.1 billion (+57.1% year-over-year).
Annual dividend increased for the 35th consecutive year to JPY 152 per share.
Outlook and guidance
2025 forecast: net sales of JPY 1.67 trillion (2.6–3.1% growth), operating income of JPY 160 billion (up JPY 13.4 billion), net income of JPY 116 billion, and EPS of JPY 249.74 (7.7% growth).
Dividend planned to increase to JPY 154 per share.
Expecting JPY 13 billion effect from earning power reforms and JPY 7 billion profit increase in cosmetics from China inventory resolution.
Cost reductions and productivity improvements to drive income increase.
Main exchange rates for forecasts: USD/JPY 150, EUR/JPY 163, CNY/JPY 21.
Latest events from Kao
- Profits and sales rose, with a share split and higher dividends planned for FY2026.4452
Q4 20256 Feb 2026 - H1 operating income up 68%, full-year outlook raised, but China remains a challenge.4452
Q2 20242 Feb 2026 - Profit and margin growth surged on reforms and premiumization, offsetting China cosmetics weakness.4452
Q3 202416 Jan 2026 - Operating income jumped 41.9% on 6.6% sales growth, with robust gains in Japan.4452
Q1 20258 Jan 2026 - Profitability and margins rose, driven by high-value products and Cosmetics recovery.4452
Q3 202516 Dec 2025 - Upward forecast revision and major share buyback follow strong H1 results and improved profitability.4452
Q2 202523 Nov 2025